Bucillamine is dead .... over .... just like we all knew months ago. Question is, can this company shift back to being a psychedelic innovator and actually do something. To be honest, based on how bad the CEO effed up the Bucillamine clinical trial, I don't have much faith. Never seen a bigger foul up.